Myriad Genetics Q2 Profit Soars 57%, Announces Acquisition

Following a number of tumultuous months, shareholders of molecular diagnostics company Myriad Genetics (NASDAQ: MYGN  ) have a reason to smile after the company delivered impressive second-quarter earnings results after the bell.

For the quarter, Myriad Genetics reported a 37% increase in revenue to $204.1 million as adjusted EPS increased a whopping 57% to $0.66.

Molecular diagnostics growth accounted for the bulk of Myriad's gains, with its oncology segment seeing sales increase 12% to $101.6 million and its women's health revenue soaring 90% to $94.6 million.

The company's BRACAnalysis test, a genetic test targeting the BRCA1 and BRCA 2 genes which are associated with a higher risk of breast and ovarian cancer, saw sales increase 28% to $141.2 million, and represented 69% of total company revenue. Similarly, the company's BART diagnostic also saw revenue rise 57% to $24.7 million.

Another bright spot for Myriad was the recent launch of its myRisk Hereditary Cancer Test which launch in September and brought in $11.5 million in revenue for the quarter.

Also after the bell, Myriad announced the acquisition of privately held Crescendo Bioscience for $270 million in cash (which will be reduced by $25 million for the repayment of a loan made to Crescendo). Crescendo's diagnostics portfolio and focus on the rheumatoid arthritis market will "enable us to move to the next level in terms of scale and growth," according to William Hagstrom, CEO of Crescendo Bioscience.

Looking ahead, and factoring in its acquisition of Crescendo, Myriad Genetics boosted its full-year 2014 revenue and EPS guidance to a new range of $740 million to $750 million and $2.09-$2.12 from its own prior forecast of $700 million to $715 million and $1.92-$1.97.


Read/Post Comments (1) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2823678, ~/Articles/ArticleHandler.aspx, 11/26/2014 1:51:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement